{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:28:06Z","timestamp":1759530486253},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2003,5,1]],"date-time":"2003-05-01T00:00:00Z","timestamp":1051747200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Science Inc"],"published-print":{"date-parts":[[2003,5]]},"DOI":"10.1007\/s11906-003-0031-z","type":"journal-article","created":{"date-parts":[[2007,5,24]],"date-time":"2007-05-24T12:02:34Z","timestamp":1180008154000},"page":"269-272","source":"Crossref","is-referenced-by-count":17,"title":["The role of the sympathetic nervous system in linking obesity with hypertension in white versus black Americans"],"prefix":"10.1007","volume":"5","author":[{"given":"Pirooz","family":"Eslami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Tuck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"Suppl 2","key":"31_CR1","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/BF02603183","volume":"4","author":"HP Dustan","year":"1990","unstructured":"Dustan HP: Obesity and hypertension in blacks. Cardiovasc Drugs Ther 1990, 4(Suppl 2):395\u2013402.","journal-title":"Cardiovasc Drugs Ther"},{"key":"31_CR2","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4614-7577-4","volume-title":"Pathophysiology of Hypertension in Blacks","author":"JCS Fray","year":"1993","unstructured":"Fray JCS, Douglas JG: Pathophysiology of Hypertension in Blacks. New York, NY: Oxford University Press; 1993."},{"key":"31_CR3","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0895-7061(97)00211-2","volume":"7","author":"R Cooper","year":"1997","unstructured":"Cooper R, Rotimi C: Hypertension in blacks. Am J Hypertens 1997, 7:804\u2013812.","journal-title":"Am J Hypertens"},{"key":"31_CR4","first-page":"304","volume":"5","author":"DA Calhoun","year":"1992","unstructured":"Calhoun DA: Hypertension in blacks: socioeconomic stress and sympathetic nervous system activity. Am J Med Sci 1992, 5:304\u2013306.","journal-title":"Am J Med Sci"},{"key":"31_CR5","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1097\/00000441-199512000-00016","volume":"310","author":"DA Calhoun","year":"1995","unstructured":"Calhoun DA, Oparil S: Racial differences in the pathogenesis of hypertension. Am J Med Sci 1995, 310:S86-S90.","journal-title":"Am J Med Sci"},{"key":"31_CR6","first-page":"60","volume":"1","author":"K Liu","year":"1993","unstructured":"Liu K, Ruth KJ, Flack JM, et al.: Blood pressure in young blacks and whites: relevance of obesity and lifestyle factors in determining differences: (The Cardia Study). Circulation 1993, 1:60.","journal-title":"Circulation"},{"key":"31_CR7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0021-9681(86)90066-4","volume":"39","author":"WB Neser","year":"1986","unstructured":"Neser WB, Thomas J, Semenya K, et al.: Obesity and hypertension in a longitudinal study of black physicians: (The Meharry Cohort Study). J Chron Dis 1986, 39:105\u2013113.","journal-title":"J Chron Dis"},{"key":"31_CR8","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1530\/acta.0.1020252","volume":"102","author":"ML Tuck","year":"1983","unstructured":"Tuck ML, Sowers JR, Dornfeld L, et al.: Reductions in plasma catecholamines and blood pressure during weight loss in obese subjects. Acta Endocrinol (Copenh) 1983, 102:252\u2013257.","journal-title":"Acta Endocrinol (Copenh)"},{"key":"31_CR9","first-page":"959","volume":"16","author":"JB Young","year":"1992","unstructured":"Young JB, Macdonald IA: Sympathoadrenal activity in human obesity: heterogeneity of findings since 1980. Int J Obes Relat Metab Disord 1992, 16:959\u2013967.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"31_CR10","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/S0024-3205(00)00568-3","volume":"66","author":"JL Gonzalez-Trapaga","year":"2000","unstructured":"Gonzalez-Trapaga JL, Nelesen RA, Dimsdale JE, et al.: Plasma Epinephrine levels in hypertension and across gender and ethnicity. Life Sci 2000, 66:2383\u20132392.","journal-title":"Life Sci"},{"key":"31_CR11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0033-0620(99)70008-3","volume":"42","author":"N Mikhail","year":"1999","unstructured":"Mikhail N, Golub MS, Tuck ML: Obesity and hypertension. Prog Cardio Dis 1999, 42:39\u201358. CMA recent and complete review of obesity and hypertension.","journal-title":"Prog Cardio Dis"},{"key":"31_CR12","first-page":"R946","volume":"260","author":"E Grossman","year":"1991","unstructured":"Grossman E, Chang PC, Hoffman A, et al.: Tracer norepinephrine kinetics: dependence on regional blood flow and the site of infusion. Am J Physiol 1991, 260:R946-R952.","journal-title":"Am J Physiol"},{"key":"31_CR13","first-page":"E505","volume":"261","author":"G Eisenhofer","year":"1991","unstructured":"Eisenhofer G, Esler MD, Goldstein DS, et al.: Neuronal uptake, metabolism, and release of tritium-labeled norepinephrine during assessment of its plasma kinetics. Am J Physiol 1991, 261:E505-E515.","journal-title":"Am J Physiol"},{"issue":"Suppl 7","key":"31_CR14","first-page":"S53","volume":"8","author":"MD Esler","year":"1990","unstructured":"Esler MD, Lambert G, Jennings GL: Increased regional sympathetic nerve activity in human hypertension: causes and consequences. J Hypertens 1990, 8(Suppl 7):S53-S57.","journal-title":"J Hypertens"},{"key":"31_CR15","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1161\/01.CIR.96.10.3423","volume":"6","author":"M Vaz","year":"1997","unstructured":"Vaz M, Jennings GL, Turner A, et al.: Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation 1997, 6:3423\u20133429.","journal-title":"Circulation"},{"key":"31_CR16","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3109\/10641969709083171","volume":"19","author":"M Esler","year":"1997","unstructured":"Esler M, Lambert G, Vaz M, et al.: Central nervous system monoamine neurotransmitter turnover in primary and obesity-related human hypertension. Clin Exp Hypertens 1997, 19:577\u2013590.","journal-title":"Clin Exp Hypertens"},{"key":"31_CR17","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s11906-002-0035-0","volume":"2","author":"K Masuo","year":"2002","unstructured":"Masuo K: Obesity-related hypertension: role of sympathetic nervous system, insulin, and leptin. Curr Hypertens Rep 2002, 2:112\u2013118.","journal-title":"Curr Hypertens Rep"},{"key":"31_CR18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1161\/01.HYP.14.2.177","volume":"14","author":"EA Anderson","year":"1989","unstructured":"Anderson EA, Sinkey CA, Lawton WJ, Mark AL: Elevated sympathetic nerve activity in borderline hypertensive man: Evidence from direct intraneuronal recordings. Hypertension 1989, 14:177\u2013183.","journal-title":"Hypertension"},{"key":"31_CR19","first-page":"363","volume":"270","author":"PP Jones","year":"1996","unstructured":"Jones PP, Snitker S, Skinner JS, Ravussin E: Gender differences in muscle sympathetic nerve activity: effect of body fat distribution. Am J Physiol 1996, 270:363\u2013366.","journal-title":"Am J Physiol"},{"key":"31_CR20","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1161\/01.HYP.27.2.276","volume":"27","author":"S Gudbjornsdottir","year":"1996","unstructured":"Gudbjornsdottir S, Lonnroth P, Sverrisdottir YB, et al.: Sympathetic nerve activity and insulin in obese normotensive and hypertensive men. Hypertension 1996, 27:276\u2013280.","journal-title":"Hypertension"},{"key":"31_CR21","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1161\/01.HYP.36.4.531","volume":"36","author":"C Weyer","year":"2000","unstructured":"Weyer C, Pratley RE, Snitker S, et al.: Ethnic differences in insulinemia and sympathetic tone as links between obesity and blood pressure. Hypertension 2000, 36:531\u2013537.","journal-title":"Hypertension"},{"key":"31_CR22","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1172\/JCI116760","volume":"92","author":"M Spraul","year":"1993","unstructured":"Spraul M, Ravussin E, Fontvieille AM, et al.: Reduced sympathetic nervous activity. A potential mechanism predisposing to body weight gain. J Clin Invest 1993, 92:1730\u20131735.","journal-title":"J Clin Invest"},{"key":"31_CR23","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1097\/00004872-199411000-00012","volume":"12","author":"DA Calhoun","year":"1994","unstructured":"Calhoun DA, Mutinga ML, Wyss JM, Oparil S: Muscle sympathetic nervous system activity in black and Caucasian hypertensive subjects. J Hypertens 1994, 12:1291\u20131296.","journal-title":"J Hypertens"},{"key":"31_CR24","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1161\/01.HYP.38.3.379","volume":"38","author":"NI Abate","year":"2001","unstructured":"Abate NI, Mansour YH, Tuncel M, et al.: Overweight and sympathetic overactivity in black Americans. Hypertension 2001, 38:379\u2013383. Most complete study comparing SNS in black and white obese subjects.","journal-title":"Hypertension"},{"key":"31_CR25","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1161\/01.CIR.98.8.772","volume":"98","author":"K Narkiewicz","year":"1998","unstructured":"Narkiewicz K, Van de Borne PJ, Cooley RL, et al.: Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation 1998, 98:772\u2013776. A landmark study showing that obstructive sleep apnea raises SNS activity in obese subjects; those without sleep apnea had normal SNS activity.","journal-title":"Circulation"},{"key":"31_CR26","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1161\/01.HYP.31.1.64","volume":"31","author":"G Grassi","year":"1998","unstructured":"Grassi G, Colombo M, Seravalle G, et al.: Dissociation between muscle and skin sympathetic nerve activity in essential hypertension, obesity, and congestive heart failure. Hypertension 1998, 31:64\u201367.","journal-title":"Hypertension"},{"key":"31_CR27","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1016\/S0895-7061(01)02077-5","volume":"14","author":"JE Hall","year":"2001","unstructured":"Hall JE, Hildebrandt DA, Kuo J: Obesity hypertension: role of leptin and sympathetic nervous system. Am J Hypertens 2001, 14:S103-S115.","journal-title":"Am J Hypertens"},{"key":"31_CR28","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1172\/JCI119532","volume":"100","author":"WG Haynes","year":"1997","unstructured":"Haynes WG, Morgan DA, Sivitz WI, et al.: Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest 1997, 100:270\u2013278.","journal-title":"J Clin Invest"},{"key":"31_CR29","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/0026-0495(89)90118-2","volume":"38","author":"JA O\u2019Hare","year":"1989","unstructured":"O\u2019Hare JA, Minaker KL, Meneilly CS, et al.: Effect of insulin on plasma norepinephrine and 3, 4 dihydroxyphenylalanine in obese men. Metabolism 1989, 38:322\u2013329.","journal-title":"Metabolism"},{"key":"31_CR30","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1161\/01.HYP.21.2.136","volume":"21","author":"EA Anderson","year":"1993","unstructured":"Anderson EA, Mark AL: The vasodilatory action of insulin. Implications for the insulin hypothesis in hypertension. Hypertension 1993, 21:136\u2013141.","journal-title":"Hypertension"},{"key":"31_CR31","first-page":"217","volume-title":"Calcium Antagonists in Clinical Medicine","author":"DB Corry","year":"1998","unstructured":"Corry DB, Tuck ML: Insulin and glucoregulatory hormones: Implications for antihypertensive therapy. In Calcium Antagonists in Clinical Medicine. Edited by Epstein M. Philadelphia: Hanley and Belfus; 1998:217\u2013241."},{"key":"31_CR32","first-page":"406","volume":"8","author":"AD Barron","year":"1996","unstructured":"Barron AD: Insulin and the vasculature\u2014old actors, new roles. J Invest Med 1996, 8:406\u2013412.","journal-title":"J Invest Med"},{"key":"31_CR33","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1172\/JCI117621","volume":"94","author":"U Scherrer","year":"1994","unstructured":"Scherrer U, Randin D, Vollenweinder P, Nicod P: Nitric oxide release accounts for insulin\u2019s vascular effects in humans. J Clin Invest 1994, 94:2511\u20132515.","journal-title":"J Clin Invest"},{"key":"31_CR34","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0895-7061(00)01279-6","volume":"14","author":"K Masuo","year":"2001","unstructured":"Masuo K, Mikami H, Ogihara T, Tuck ML: Weight reduction and pharmacologic treatment in obese hypertensives. Am J Hypertens 2001, 14:530\u2013538.","journal-title":"Am J Hypertens"},{"key":"31_CR35","first-page":"145","volume":"30","author":"E Reisen","year":"1997","unstructured":"Reisen E, Weir MR, Falkner B, et al.: Lisinopril versus hydrochlorothiazide in obese hypertensive patients. A Multicenter placebo-controlled trial. Hypertension 1997; 30(Pt1):145\u2013155.","journal-title":"Hypertension"},{"key":"31_CR36","first-page":"161","volume-title":"Calcium Antagonists in Clinical Medicine","author":"DB Corry","year":"2002","unstructured":"Corry DB, Tuck ML: Implications of glucoregulatory hormones in antihypertensive therapy. In Calcium Antagonists in Clinical Medicine, edn 3. Philadelphia: Hanley & Belfus; 2002:161\u2013180.","edition":"edn 3"},{"issue":"Suppl 1","key":"31_CR37","first-page":"167","volume":"19","author":"ML Tuck","year":"1992","unstructured":"Tuck ML: Obesity, the sympathetic nervous system and essential hypertension. Hypertension 1992, 19(Suppl 1):167\u2013177.","journal-title":"Hypertension"},{"key":"31_CR38","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1161\/01.HYP.25.4.560","volume":"25","author":"G Grassi","year":"1995","unstructured":"Grassi G, Seravelle G, Cattaneo BM, et al.: Sympathetic activation in obese normotensive subjects. Hypertension 1995, 25:560\u2013563.","journal-title":"Hypertension"},{"key":"31_CR39","first-page":"25","volume":"1","author":"L Landsberg","year":"1996","unstructured":"Landsberg L: Insulin and the sympathetic nervous system in the pathophysiology of hypertension. Blood Press Suppl 1996, 1:25\u201329.","journal-title":"Blood Press Suppl"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-003-0031-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11906-003-0031-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-003-0031-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:16:05Z","timestamp":1559420165000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11906-003-0031-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,5]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,5]]}},"alternative-id":["31"],"URL":"https:\/\/doi.org\/10.1007\/s11906-003-0031-z","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,5]]}}}